LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus

Jody L Floyd1, Kenneth P Smith, Sanath H Kumar

  • 1Eastern New Mexico University, Department of Biology, Station 33, Portales, NM 88130, USA.

Insights

A novel multidrug efflux pump, LmrS, was identified in Staphylococcus aureus. This transporter confers resistance to critical antibiotics like linezolid and trimethoprim.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Multidrug efflux pumps are crucial in antimicrobial resistance.
  • The major facilitator superfamily (MFS) includes many clinically relevant transporters.
  • Staphylococcus aureus possesses various resistance mechanisms, including efflux pumps.

Purpose of the Study:

  • To clone and characterize a novel multidrug efflux pump, LmrS, from Staphylococcus aureus.
  • To evaluate the role of LmrS in the efflux of various antimicrobial agents.
  • To determine the substrate specificity of the LmrS transporter.

Main Methods:

  • Cloning of the LmrS gene from Staphylococcus aureus.
  • Determination of minimum inhibitory concentrations (MICs) for various compounds in the presence and absence of LmrS.
  • Bioinformatic analysis to predict the structure and homology of LmrS.

Main Results:

  • The LmrS efflux pump was successfully cloned and expressed.
  • LmrS conferred a significant increase in MIC values for linezolid (16-fold) and tetraphenylphosphonium chloride (TPCL) (16-fold).
  • Increased resistance was also observed for sodium dodecyl sulfate (SDS), trimethoprim, and chloramphenicol (8-fold).

Conclusions:

  • LmrS is a functional multidrug efflux pump belonging to the MFS transporter family.
  • LmrS contributes to Staphylococcus aureus resistance against clinically important antibiotics and biocides.
  • LmrS exhibits homology to lincomycin resistance proteins in other bacterial species, suggesting conserved resistance mechanisms.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...